Unregistered Sales of Equity Securities and Use of Proceeds
−Removed: as previously disclosed in our current reports on Form 8-K filed prior to the date of this Form 10-Q, we did not sell any unregistered
−Removed: securities or repurchase any of our securities during the three months ended September 30, 2023.
−Removed: October 14, 2021, we completed our initial public offering (“IPO”) of our common stock under an effective registration statement
−Removed: on Form S-1 (SEC File No.
−Removed: As of September 30, 2023, of the net proceeds of $64.4 million, approximately $64.4 million has
−Removed: been used, in a manner consistent with the use of proceeds set forth in the prospectus for our IPO, as follows:
−Removed: approximately $7.5 million
−Removed: of net repayments of Due To:
−Removed: approximately $5.0 million for the purchase of our laboratory equipment, software, and its
−Removed: operating expenses;
−Removed: and $51.9 million of working capital expenditures.
−Removed: None of the proceeds have been paid to any of our directors, officers,
−Removed: 10% stockholders, or affiliates, other than as described above.
+Added: March 22, 2024, the Company approved the issuance to an investor relations firm it had engaged a three-year option to acquire 100,000
+Added: shares of the Company’s common stock, with an exercise price of $1.50 per share.
+Added: The option vests in two equal installments on
+Added: May 31, 2024 and August 31, 2024.
+Added: The offer and sale of the option and the underlying shares of common stock is exempt from the registration
+Added: requirements of the Securities Act of 1933, as amended (the “Securities Act”), pursuant to Section 4(a)(2) of the Securities
+Added: Act, as a transaction not involving a public offering.
+Added: as set forth above and as previously disclosed in our current reports on Form 8-K filed prior to the date of this Form 10-Q and in
+Added: the Annual Report, we did not sell any unregistered securities or repurchase any of our securities during the three months ended
+Added: March 31, 2024.
+Added: Part I, Item 2 under the caption “ Liquidity and Capital Resources ” for a description of limitations on the payment of dividends.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.